N. 6 - 28 mar 2012
International info a cura di Cecilia Migali
"We have created a European Research Council to stimulate fundamental research, but we do not have a strategy as to how to fill the gap between basic disciplines and clinical research in the health area". So spoke Julio E. Celis, of the European Cancer Organization (Ecco) Policy Committee, Alliance for Biomedical Research in Europe (BioMed Alliance), who attended the Conference 'A focus on the future of cancer research in Europe', recently organized by Cnr-Institute of Protein Biochemistry in Naples.
According to Celis, who is also the scientific director of the Institute of Cancer Biology at the Danish Cancer Society in Copenhagen, although Europe has well-organized clinical and basic/preclinical cancer centres in the member states, there are several barriers that preclude us from taking advantage of the scientific expertise and resources available, such as the fragmentation and duplication of research activities. Moreover, he remarked on that collaboration between the industry and academia has been limited and the increasing migration of top scientists and students to the Usa has proven to be detrimental.
Recently, the innovation Union - Europe's 2020 strategy to stimulate growth - pledged to move discoveries quicker to the market in an effort to generate more jobs, improve lives, and achieve a better society. "Yet, this ambitious undertaking", Celis said "does not provide strategic solutions as to how to tackle the health research challenges, cancer included, posed by administrative and regulatory complexity, lack of coordination and sustainability of current research programmes, as well as the fact that the length of the innovation cycle in health research is very long. The oncology community together with experts in diabetes, cardiology, respiratory and other diseases believe that these considerations need to be addressed if discoveries are to reach the bedside as promised by the Innovation Union".
"In particular, the biomedical community has proposed the creation of the European Council for Health Research (Euchr)", added the scientist "a bottom-up structure that will have a structural effect in organising biomedical research and that should ensure expert scientific input on policy from the outset, provide funding to advance research and innovation and competitiveness, encourage participation by researchers across borders and beyond, and warrant savings for national health systems in times of economic crisis".
"The aim is to speed up the translation of discoveries into applications that impact healthcare delivery and to ensure that society benefits from the outcome of research", concluded Celis.
Fonte: Julio E. Celis, Danish Cancer Society, email email@example.com